|
Updated outcomes with axicabtagene ciloleucel (axi-cel) retreatment (reTx) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) in ZUMA-5. |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; precision biosciences |
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Humanigen; Kite/Gilead; Lonza; Nkarta; Novartis; Precision Biosciences |
Speakers' Bureau - Axis Bioservices; Clinical Care Options |
Research Funding - Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer |
Travel, Accommodations, Expenses - Kite/Gilead; Novartis; Precision Biosciences |
| |
|
Research Funding - Gilead Sciences; Juno/Bristol-Myers Sqibb; Kite, a Gilead Company |
| |
|
Honoraria - Aptitude Health; Bio Ascend; Medscape; MJH Life Sciences |
Consulting or Advisory Role - Adicet Bio; Alimera Sciences; Bristol-Myers Squibb; Calibr; Celgene; Cell Medica; Gilead Sciences; Incyte; Kite, a Gilead company; Legend Biotech; Merck Sharp & Dohme; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics |
Research Funding - Acerta Pharma; Alimera Sciences; Bristol-Myers Squibb; Cellectis; Gilead Sciences; Karus Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; poseida therapeutics; Precision Biosciences; Unum Therapeutics |
Patents, Royalties, Other Intellectual Property - Patents related to cellular therapy; Royalty income from Takeda Pharmaceuticals |
Travel, Accommodations, Expenses - Alimera Sciences; Celgene; Chugai Pharma; Kite/Gilead; Legend Biotech; Medscape; Merck; Novartis; Pfizer; Precision Biosciences; Unum Therapeutics |
| |
|
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech/Roche; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Legend Biotech; MorphoSys; Novartis; Pharmacyclics |
Consulting or Advisory Role - A2 Biotherapeutics |
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst) |
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents. |
| |
|
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche/Genentech |
Consulting or Advisory Role - Alimera Sciences; BeiGene; Bristol-Myers Squibb; Celgene; Debiopharm Group; Epizyme; Genmab; Genmab; Gilead Sciences; Incyte; Janssen; Miltenyi Biotec; morphosys; Novartis; Roche/Genentech; Velosbio |
| |
|
Consulting or Advisory Role - Celgene; Guidepoint Global; Kyowa Hakko Kirin; miRagen; Navicor; Triangle Insights Group |
Research Funding - Dova Pharmaceuticals; Incyte; Innate Pharma; Kite/Gilead; Merck; miRagen |
| |
|
Employment - Kite, a Gilead Company |
| |
|
Employment - Kite, a Gilead Company |
Stock and Other Ownership Interests - Gilead Sciences |
| |
|
Employment - Kite, a Gilead Company |
Stock and Other Ownership Interests - Five Prime Therapeutics; Kite, a Gilead Company |
Travel, Accommodations, Expenses - Kite, a Gilead Company |
| |
|
Employment - Kite, a Gilead Company |
Stock and Other Ownership Interests - Kite, a Gilead Company |
Honoraria - Kite, a Gilead Company |
Patents, Royalties, Other Intellectual Property - Genentech |
Travel, Accommodations, Expenses - Kite, a Gilead Company |
| |
|
Employment - Kite, a Gilead Company |
Stock and Other Ownership Interests - Gilead Sciences; Kite, a Gilead Company |
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center; NYBC |
Travel, Accommodations, Expenses - Gilead Sciences |